Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial

被引：0
|
作者：
Morrow, David A.
Cannon, Christopher P.
Zannad, Faiz
Cushman, William C.
Bakris, George L.
Nissen, Steven E.
Heller, Simon R.
Bergenstal, Richard M.
Perez, Alfonso T.
Fleck, Penny R.
Mehta, Cyrus R.
Kupfer, Stuart
Lam, Hung
Wilson, Craig
White, William B.
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diabetes (Type II); Coronary heart disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17295
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Long-term fenofibrate therapy and cardiovascular events in people with type 2 diabetes mellitus (the FIELD study: randomised controlled trial)
    不详
    KARDIOLOGIYA, 2006, 46 (01) : 70 - 72
  • [42] Coronary Artery Calcium Score Predicts Long-Term Cardiovascular Outcomes in Asymptomatic Patients with Type 2 Diabetes
    Lei, Meng-Huan
    Wu, Yu-Lin
    Chung, Sheng-Liang
    Chen, Chao-Chin
    Chen, Wei-Cheng
    Hsu, Yu-Chen
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (10) : 1052 - 1062
  • [43] MODELING THE LONG-TERM COSTS AND OUTCOMES OF ANTIDIABETICS IN PATIENTS WITH TYPE 2 DIABETES AT HIGH RISK OF CARDIOVASCULAR EVENTS
    Zheng, Y.
    Sorensen, S.
    Palencia, R.
    Ruffolo, A.
    Hass, B.
    Kansal, A.
    VALUE IN HEALTH, 2014, 17 (03) : A247 - A247
  • [44] Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)
    Cavender, Matthew A.
    White, William B.
    Jarolim, Petr
    Bakris, George L.
    Cushman, William C.
    Kupfer, Stuart
    Gao, Qi
    Mehta, Cyrus R.
    Zannad, Faiez
    Cannon, Christopher P.
    Morrow, David A.
    CIRCULATION, 2017, 135 (20) : 1911 - +
  • [45] Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial
    Home, PD
    Lindholm, A
    Riis, A
    DIABETIC MEDICINE, 2000, 17 (11) : 762 - 770
  • [46] Benefits of long-term finofibrate therapy on amputations in type 2 diabetes mellitus in the FIELD trial
    Colman, P.
    Rajamani, K.
    Li, L. -P.
    D'Emden, M.
    Voysey, M.
    Keech, A.
    DIABETOLOGIA, 2008, 51 : S549 - S550
  • [47] Long-term β-carotene supplementation and risk of type 2 diabetes mellitus -: A randomized controlled trial
    Liu, SM
    Ajani, U
    Chae, C
    Hennekens, C
    Buring, JE
    Manson, JE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (11): : 1073 - 1075
  • [48] Cerebrovascular reactivity in patients with long-term type 1 diabetes mellitus with and without cardiovascular autonomic neuropathy
    Mankovsky, B. N.
    Saenko, Y.
    Kovalenko, A.
    Likhoshapko, O.
    DIABETOLOGIA, 2012, 55 : S477 - S477
  • [49] Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis
    Lu, Hongtao
    Tang, Bing
    Zhou, Yanhua
    Xu, Chenhong
    Bundhun, Pravesh Kumar
    Tang, Zhangui
    Bao, Hong
    DIABETES THERAPY, 2019, 10 (04) : 1487 - 1497
  • [50] Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis
    Hongtao Lu
    Bing Tang
    Yanhua Zhou
    Chenhong Xu
    Pravesh Kumar Bundhun
    Zhangui Tang
    Hong Bao
    Diabetes Therapy, 2019, 10 : 1487 - 1497
12345